Why emerging market investors should enjoy the surge inspired by Biden and vaccines while it lasts
- The mix of unprecedented monetary and fiscal stimulus and expectations that mass vaccination programmes will end the pandemic has sparked an extended rally
- However, with mounting unease about speculative bubbles and asset prices reliant on bond yields staying at historic lows, investors should not get carried away

Emerging markets have begun the year with a bang. In the first three weeks of 2021, investors poured US$25.4 billion into emerging market bond and equity funds. This is almost exactly the same amount as the total inflows for the whole of 2020, according to data from JPMorgan.
Since late last March, the MSCI Emerging Markets Index, a leading gauge of stocks in developing economies, has soared more than 80 per cent, to an all-time high. It has exceeded its peak just before the eruption of the 2008 financial crisis.
The corporate bonds of developing economies are also on a tear. The average yield on JPMorgan’s index of emerging market corporate bonds stands a whisker above its record low.

01:47
China GDP: economy grew by 4.9 per cent in third quarter of 2020
